2nd Quarter - Report

CAPITOL SOLUTIONS for AMGEN USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to State Children's Health Insurance Program (SCHIP) H.R. 5629, To establish a pathway for licensure of biosimilars biological products Issues related to ESRD bundling formula

LobbyistCovered position, as disclosed
DON LYSTER —
DANIEL C TATE —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 5629 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.